{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:08:34Z","timestamp":1740175714419,"version":"3.37.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda y Cirujanos"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.circir.2016.10.031","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T11:33:59Z","timestamp":1484825639000},"page":"478-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurodesarrollo en pacientes con retinopat\u00eda del prematuro tratados con bevacizumab intrav\u00edtreo. Serie de casos"],"prefix":"10.1016","volume":"85","author":[{"given":"Sarah Melania","family":"Mart\u00ednez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Eustolio","family":"Hern\u00e1ndez-Da Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Rubio-Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Rojas-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra Edith","family":"Vieyra-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Ana","family":"Mart\u00ednez-Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Zavala-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anel","family":"G\u00f3mez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.circir.2016.10.031_bib0055","first-page":"1687","article-title":"Prevalence of retinopathy of prematurity in Latin America","volume":"5","author":"Carrion","year":"2011","journal-title":"Clin Ophthalmol."},{"key":"10.1016\/j.circir.2016.10.031_bib0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7196\/SAMJ.6131","article-title":"Prevalence of and risk factors for retinopathy of prematurity in a cohort of preterm infants treated exclusively with non-invasive ventilation in the first week birth","volume":"103","author":"Van der Merwes","year":"2013","journal-title":"S Afr Med J."},{"key":"10.1016\/j.circir.2016.10.031_bib0065","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1651-2227.2011.02330.x","article-title":"On the use of antiangiogenetic medications for retinopathy of prematurity","volume":"100","author":"Hard","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.circir.2016.10.031_bib0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Pan merican Colloborative Retina Group (PACORES). Twelve-month safety of intravitreal injections of bevacizumab (Avastin) results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.circir.2016.10.031_bib0075","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmakokinetics of intravitreal ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology."},{"key":"10.1016\/j.circir.2016.10.031_bib0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.circir.2016.10.031_bib0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1289\/ehp.00108s3511","article-title":"Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models","volume":"108","author":"Rice","year":"2000","journal-title":"Environ Health Perspec."},{"key":"10.1016\/j.circir.2016.10.031_bib0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/02713683.2014.941070","article-title":"Preliminary anatomical and neurodevelopmental outcomes of intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity","volume":"40","author":"Araz-Ersan","year":"2015","journal-title":"Curr Eye Res."},{"key":"10.1016\/j.circir.2016.10.031_bib0095","first-page":"225","article-title":"L\u00e1ser-ranibizumab para tratar retinopat\u00eda del prematuro en estadio umbral-preumbral. Tres a\u00f1os de experiencia","volume":"79","author":"Orozco-G\u00f3mez","year":"2011","journal-title":"Cir Cir."},{"key":"10.1016\/j.circir.2016.10.031_bib0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/IAE.0b013e318275394a","article-title":"Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up","volume":"33","author":"Mart\u00ednez-Castellanos","year":"2013","journal-title":"Retina."}],"container-title":["Cirug\u00eda y Cirujanos"],"original-title":[],"language":"es","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0009741116301189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0009741116301189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T15:50:53Z","timestamp":1539877853000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009741116301189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0009741116301189"],"URL":"https:\/\/doi.org\/10.1016\/j.circir.2016.10.031","relation":{},"ISSN":["0009-7411"],"issn-type":[{"type":"print","value":"0009-7411"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodesarrollo en pacientes con retinopat\u00eda del prematuro tratados con bevacizumab intrav\u00edtreo. Serie de casos","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda y Cirujanos","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.circir.2016.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Academia Mexicana de Cirug\u00eda A.C. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}